BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 7976715)

  • 21. [Prostate cancer after prostatectomy for benign prostatic hyperplasia].
    Hua L; Zhang J; Wu H; Sui Y; Zhang W; Qian L; Wang Z
    Zhonghua Nan Ke Xue; 2004 Aug; 10(8):612-3. PubMed ID: 15362527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Urgent problems of prostatic cancer diagnosis in a small district clinic].
    Komarov RN; Gordetsov AS; Komarov NV; Kanashkin OV; Svetozrskiĭ NL; Gamaiunov SV
    Urologiia; 2006; (3):28-9, 31. PubMed ID: 16889086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Granulomatous prostatitis. Differential diagnosis from cancer of the prostate].
    Møller-Nielsen C; Sell A
    Ugeskr Laeger; 1983 Mar; 145(13):994-5. PubMed ID: 6857812
    [No Abstract]   [Full Text] [Related]  

  • 24. Self-report of prostatitis and its risk factors in a random sample of middle-aged men.
    Rothman I; Stanford JL; Kuniyuki A; Berger RE
    Urology; 2004 Nov; 64(5):876-9; discussion 879-80. PubMed ID: 15533468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
    Iwaki H; Kajita Y; Shimizu Y; Yamauchi T
    Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of transurethral resection of the prostate and biopsy of the peripheral zone in the same session after repeated negative biopsies in the diagnosis of prostate cancer.
    Puppo P; Introini C; Calvi P; Naselli A
    Eur Urol; 2006 May; 49(5):873-8. PubMed ID: 16439052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-prostatic massage examination for prediction of asymptomatic prostatitis in needle biopsies: a prospective study.
    Tekin A; Yuksel A; Tekin S; Gumrukcu G; Aslan AR; Sengor F
    J Urol; 2009 Aug; 182(2):564-8; discussion 568-9. PubMed ID: 19524953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chronic prostatic inflammation: a confounding factor in the diagnosis of prostatic cancer].
    Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Burgos Revilla FJ; Jiménez Cidre M; García González R
    Arch Esp Urol; 1996 Sep; 49(7):669-73. PubMed ID: 9020002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-specific granulomatous prostatitis treated with steroids.
    Saha PK; Hyakutake H; Nomata K; Yushita Y; Kanetake H; Saito Y
    Hinyokika Kiyo; 1991 Aug; 37(8):927-30. PubMed ID: 1957740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Summary of our clinical experience with the determination of serum prostate-specific antigen level in the first five years].
    Bánfi G; Kiss F; Kádár A; Romics I
    Magy Onkol; 2003; 47(2):165-8. PubMed ID: 12975664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulomatous prostatitis: confusion clinically with carcinoma of the prostate.
    Taylor EW; Wheelis RF; Correa RJ; Gibbons RP; Mason JT; Cummings KB
    J Urol; 1977 Mar; 117(3):316-8. PubMed ID: 839592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME
    Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen.
    Potts JM
    J Urol; 2000 Nov; 164(5):1550-3. PubMed ID: 11025702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Granulomatous prostatitis. Analysis of 15 cases and review of the literature].
    Madrid García FJ; Alvarez Ferreirra J; Núñez Mora C; López Tello J; García Cardoso JV; Picazo García ML; Martínez-Piñeiro JA
    Arch Esp Urol; 1996 Oct; 49(8):789-95. PubMed ID: 9065275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do changes in a high serum prostate-specific antigen level and the free/total prostate-specific antigen ratio after antibiotic treatment rule out biopsy and the suspicion of cancer?
    Dirim A; Tekin MI; Koyluoglu E; Oguzulgen AI; Peskircioglu L; Ozkardes H
    Urol Int; 2009; 82(3):266-9. PubMed ID: 19440011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.
    Morote J; Raventós CX; Lorente JA; Lopez-Pacios MA; Encabo G; de Torres I; Andreu J
    J Urol; 1997 Aug; 158(2):502-4. PubMed ID: 9224333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of chronic prostatitis lowers serum prostate specific antigen.
    Bozeman CB; Carver BS; Eastham JA; Venable DD
    J Urol; 2002 Apr; 167(4):1723-6. PubMed ID: 11912396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Granulomatous Prostatitis : Three Cases Report].
    Ikeda J; Murakami S; Kawa G; Shibuya S
    Hinyokika Kiyo; 2019 Mar; 65(3):69-73. PubMed ID: 31067846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of urinary white blood cell count and serum C-reactive protein level for detection of non-palpable prostate cancer.
    Kato T; Suzuki H; Komiya A; Imamoto T; Naya Y; Tobe T; Ichikawa T
    Int J Urol; 2006 Jul; 13(7):915-9. PubMed ID: 16882055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulomatous prostatitis.
    Uzoh CC; Uff JS; Okeke AA
    BJU Int; 2007 Mar; 99(3):510-2. PubMed ID: 17092284
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.